Cambridge Healthtech Institute’s Third Annual

Genomics in Medicine

Data-Driven Personalized Diagnostics for Improved Outcomes

February 19-20, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd International Molecular Medicine Tri-Conference

 

The rapid decline in cost and widespread utilization of patient genomic information is now dramatically impacting clinical research—offering significant benefits to patients, clinicians, researchers and developers working to accurately diagnose pathologies and deliver personalized treatments. The Genomics in Medicine symposium will once again gather stakeholders to discuss advances highlighting the clinical utility of patient sequencing; emerging diagnostic approaches; interpreting, managing, reporting and returning genomic data/information; as well as utilizing genomic data to guide treatment.


Clinical Utility of Genomic Information 

Keynote Presentation: Updates on the Harvard MedSeq Study – The First Randomized Clinical Trial of Whole Genome Sequencing Vs. Standard of Care

Robert C. Green, M.D., MPH, Director, G2P Research Program; Associate Director, Research, Partners Center for Personalized Genetic Medicine, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School

The Vision and the Reality: One Cancer Center’s Journey toward Genomic Medicine

Jeff Boyd, Ph.D., Senior Vice President, Molecular Medicine; The Robert C. Young., Chair in Cancer Research; Executive Director, Cancer Genome Institute; Chief, Division of Molecular Pathology; Professor, Cancer Biology Program, Fox Chase Cancer Center

The Impact of Genomic Variation in Clinical Development

Hakon Hakonarson, M.D., Ph.D., Director, Center for Applied Genomics, Children’s Hospital of Philadelphia


Practical Considerations for Integration of Genome Data 

Integration of Genomics into Medical Practice: Educational Challenges

Bruce R. Korf, M.D., Ph.D., Wayne H. and Sara Crews Finley Chair in Medical Genetics; Professor and Chair, Department of Genetics; Director, Heflin Center for Genomic Sciences, University of Alabama at Birmingham

Navigating the Genome: Realizing the True Promise of Genomic Medicine in the Clinic

James Evans, M.D., Ph.D., Bryson Distinguished Professor, Genetics and Medicine, Department of Genetics, University of North Carolina School of Medicine


Technological Advances in NGS Diagnostics

Paradigm Cancer Diagnostic (PCDx): Development of a Clinical-Grade Next-Generation Sequencing Test for Cancer Patients

Robert Penny, M.D., Ph.D., CEO, Paradigm


Enabling Translational Diagnostics through Discovery and Development of Signatures with Unified DNA and RNA NGS Panels

Brian Haynes, Ph.D., Senior Scientist, Asuragen


Annotating and Interpreting Variants

Reinterpreting Results from Large-Scale Clinical Sequencing or Genetic Testing

Peter Byers, M.D., Director, Center for Precision Diagnostics; Professor, Pathology, Medicine & Genome Sciences, University of Washington School of Medicine

Genomic Approaches to Causal Variant Identification

Gregory Cooper, Ph.D., Faculty Investigator, HudsonAlpha Institute for Biotechnology

Genetic Dimensionality Informs Precision Cancer Medicine

Hanlee Ji, M.D., Assistant Professor, Division of Oncology, Department of Medicine, Stanford University School of Medicine; Senior Associate Director, Stanford Genome Technology Center

 

Sharing and Mining Patient Data

Impact & Utilization of Integrating Genomic Data into EMRs

Dan Roden, M.D., William Stokes Professor, Experimental Therapeutics; Professor, Medicine and Pharmacology; Assistant Vice Chancellor, Personalized Medicine, Vanderbilt University

Mining Clinical Genomic Data

Joel Dudley, Ph.D., Director, Biomedical Informatics; Assistant Professor of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai

ClinGen: Sharing Genomic Variant Data to Increase Knowledge and Improve Patient Care

Christa Lese Martin, Ph.D., FACMG, Director & Senior Investigator, Autism & Developmental Medicine Institute (ADMI), Geisinger Health System



For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 

 

 

  2015 Plenary Sessions 

2015 MMTC Prelim Agenda 

Premier Sponsors:

Elsevier 


Jackson Laboratory - small logo 

Leica Biosystems 
 

 NanoString2   

 

Singulex 

Thomson Reuters-Large 


Local Partners:

BayBio 


biocube 


Cabs 

City of SSF